Clinical trial · Interventional
Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
A Randomized Controlled Study on Early Intervention of Airwave Compression Therapy to Prevent Breast Cancer-related Upper Limb Lymphedema
NCT06495034CI-TRIAL-00078700unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to explore the effectiveness of early intervention of airwave compression therapy to prevent the occurrence of postoperative breast cancer-related lymphedema(BCRL).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| airwave compression therapy | Device | — | UNRESOLVED |
| standard care: health education and routine functional exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- control group
- description
- standard care: health education and routine functional exercise
- interventionNames
- Other: standard care: health education and routine functional exercise
- type
- EXPERIMENTAL
- label
- experimental group
- description
- 1. standard care: health education and routine functional exercise; 2. airwave compression therapy
- interventionNames
- Device: airwave compression therapy
- Other: standard care: health education and routine functional exercise
Primary outcomes (1)
- measure
- Incidence of lymphedema
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Volunteer to participate in this clinical trial. Fully understand and be informed about the study and sign an informed consent form (ICF). Willing to follow and able to complete all test procedures; * Female, ≥18 years old and ≤70 years old at the time of signing the ICF; * Patients with unilateral breast cancer diagnosed by histopathology or cytology; * No distant metastasis; * To undergo unilateral axillary sentinel lymph node biopsy or unilateral axillary lymph node dissection; * Have not received any treatment for arm lymphedema; * No lymphangitis and other infections. Exclusion Criteria: * Breast malignancy derived from other tumors rather than the primary breast cancer; * Patients with second primary tumor; * Contraindication to airwave compression therapy: Acute venous thrombosis; Acute inflammatory skin disease; Erysipelas; Arrhythmia; Pulmonary edema; Unstable hypertension; People with artificial pacemakers; Deep thrombophlebitis; * Have a history of mental illness or other reasons can not cooperate with treatment; * Embolism, cardiogenic edema, hepatogenic edema and the history of upper limb trauma and other related complications; * Patients using any medication that affects fluid or electrolyte balance.
References
Publications (0)
Data not yet available
No reference posted for this study.